[18F]ACI-19626 PET in TDP-43 Proteinopathies

Clinical trial NCT06891716 · RECRUITING

Trial details

NCT number: NCT06891716
Sponsor: AC Immune SA
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Frontotemporal Dementia (FTD)Amyotrophic Lateral Sclerosis (ALS)TDP-43 Proteinopathies Suspected Limbic Predominant Age-related TDP-43 Encephalopathy (LATE)Alzheimer's Disease (AD)

Start date: 2025-01-21
Primary completion: 2026-11-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.